HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.
HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.
复制标题
HRD1通过促进IGF-1R降解抑制乳腺癌细胞的生长和转移
DOI:
10.18632/oncotarget.5733
复制
发表时间:
2015-12-15
期刊:
影响因子:
--
通讯作者:
Su DM
中科院分区:
文献类型:
--
作者:
Xu YM;Wang HJ;Chen F;Guo WH;Wang YY;Li HY;Tang JH;Ding Y;Shen YC;Li M;Xuan WY;Liu LH;Wang J;Wang XR;Gao ZJ;Liang XB;Su DM
HRD1 (3-hydroxy-3-methylglutaryl reductase degradation) is an E3 ubiquitin ligase. We found that HRD1 was significantly downregulated in 170 breast cancer tissues. Low tumoral HRD1 expression was correlated with clinicopathological characteristics and a shorter survival in breast cancer patients. P65 specifically bound to the HRD1 promoter and inhibited HRD1 expression. Suppression of NF-κB activity reversed IL-6-induced downregulation of HRD1 expression. HRD1 interacted with IGF-1R and promoted its ubiquitination and degradation by the proteasome. Overexpression of HRD1 resulted in the inhibition of growth, migration and invasion of breast cancer cells in vitro and in vivo. Furthermore, HRD1 attenuated IL-6-induced epithelial-mesenchymal transition in MCF10A cells. These findings uncover a novel role for HRD1 in breast cancer.